Azenta Financial Results
Azenta reported fiscal fourth quarter and full year 2026 results, with Q4 revenue growing 5% year-over-year to $167 million. The company completed the sale of its B Medical Systems business during the year and is focusing on driving organic growth and profitability in its Multiomics and Sample Management segments for fiscal 2027.
- Term
- FY2026
“We closed fiscal 2026 with improving momentum, delivering stronger performance in the second half of the year. Our businesses have strong market positions and differentiated capabilities, and we are seeing progress from our efforts to improve commercial execution and operating efficiency.”
Dr. Martin Madaus, Interim President and Chief Executive Officer
“Fiscal 2027 is about consistent execution and accelerating performance. We are focused on driving organic growth, expanding profitability and cash generation, and executing on our strategic initiatives.”
Dr. Martin Madaus, Interim President and Chief Executive Officer